Nitrofurantoin BE study [Regulatives / Guidelines]

posted by pjs – India, 2015-08-27 17:36 (3454 d 01:15 ago) – Posting: # 15359
Views: 11,433

Dear all,

Apologies for the consecutive post.

❝ Please suggest statistical evaluation of tmax is required in this BE study or not.


Pls share your views for the mentioned.

How to decide what is clinically relevant and what is not?

What is the usual practice? to keep the Statistical evalution of Tmax or not?

What justification can be given if statistically significant diff is found between Tmax of test and ref but BE criteria is fulfilled in terms of Cmax nad AUC.

Regards,
PJS

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,662 registered users;
260 visitors (0 registered, 260 guests [including 15 identified bots]).
Forum time: 17:51 CET (Europe/Vienna)

There are sadistic scientists who hurry to hunt down errors
instead of establishing the truth.    Marie Curie

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5